194 related articles for article (PubMed ID: 10444126)
1. Who should manage germ cell tumours of the testis?
Mead GM
BJU Int; 1999 Jul; 84(1):61-7. PubMed ID: 10444126
[No Abstract] [Full Text] [Related]
2. Is surveillance for stage 1 germ cell tumours of the testis appropriate outside a specialist centre?
Jones A; Fergus JN; Chapman J; Houghton L
BJU Int; 1999 Jul; 84(1):79-84. PubMed ID: 10444129
[TBL] [Abstract][Full Text] [Related]
3. Germ cell tumors.
Bajorin DF; Motzer RJ; Bosl GJ
Curr Ther Endocrinol Metab; 1994; 5():354-9. PubMed ID: 7535661
[No Abstract] [Full Text] [Related]
4. [Case report: simultaneous bilateral testicular tumors with different cell types].
Yanagihara Y; Sawada Y; Ozaw A; Nishid T; Kikugawa T; Ikeda T; Shimamoto K; Aoki K; Tanji N; Iio S; Yokoyam M
Nihon Hinyokika Gakkai Zasshi; 2010 Mar; 101(3):574-8. PubMed ID: 20387519
[TBL] [Abstract][Full Text] [Related]
5. [Current procedure for treating testicular germ-cell tumors].
Tiuliandin SA; Figurin KM; Garin AM
Urol Nefrol (Mosk); 1995; (6):40-4. PubMed ID: 8686125
[TBL] [Abstract][Full Text] [Related]
6. Intracranial granulocytic sarcoma after chemotherapy for pineal germinoma and testicular cancer.
Passarin MG; Vattemi E; Musso AM; Romito S; Moretto G; Ghimenton C; Iuzzolino P; Doglioni C; Pedersini R
J Clin Oncol; 2008 Sep; 26(27):4507-9. PubMed ID: 18802163
[No Abstract] [Full Text] [Related]
7. Retroperitoneal metastatic germ-cell testis cancer, presenting different findings on computed tomography and different responses to chemotherapy.
Suzuki K; Shimizu N; Kurokawa K; Suzuki T; Imai K; Yamanaka H
Br J Urol; 1996 Apr; 77(4):608-10. PubMed ID: 8777633
[No Abstract] [Full Text] [Related]
8. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
Fléchon A; Biron P; Philip I; Blay JY; Droz JP
Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344
[TBL] [Abstract][Full Text] [Related]
9. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
10. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
11. Germ cell neoplasms and other malignancies of the mediastinum.
Hainsworth JD; Greco FA
Cancer Treat Res; 2001; 105():303-25. PubMed ID: 11224992
[No Abstract] [Full Text] [Related]
12. The management of non-seminomatous germ cell tumours (GCT).
Paz-Ares L; Lianes P; Cortes-Funes H
Ann Oncol; 1994 May; 5(5):457-62. PubMed ID: 7521207
[No Abstract] [Full Text] [Related]
13. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
Amato RJ; Ro JY; Ayala AG; Swanson DA
Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
[TBL] [Abstract][Full Text] [Related]
14. Carboplatin in the combination chemotherapy of non-seminomatous germ cell tumours.
Horwich A; Bliss J
Ann Oncol; 1996 Dec; 7(10):989-91. PubMed ID: 9037354
[No Abstract] [Full Text] [Related]
15. Short-course etoposide, bleomycin and cisplatin in the treatment of metastatic germ cell tumours. Appraisal of its potential as adjuvant chemotherapy for stage 1 testis tumours.
Oliver RT; Dhaliwal HS; Hope-Stone HF; Blandy JP
Br J Urol; 1988 Jan; 61(1):53-8. PubMed ID: 2449257
[TBL] [Abstract][Full Text] [Related]
16. Germ cell cancer.
Oliver RT
Curr Opin Oncol; 1999 May; 11(3):236-41. PubMed ID: 10328600
[TBL] [Abstract][Full Text] [Related]
17. Part II: testicular cancer--management of advanced disease.
Jones RH; Vasey PA
Lancet Oncol; 2003 Dec; 4(12):738-47. PubMed ID: 14662430
[TBL] [Abstract][Full Text] [Related]
18. Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
Gerl A; Clemm C; Schmeller N; Dienemann H; Weiss M; Kriegmair M; Löhrs U; Wilmanns W
Br J Cancer; 1994 Nov; 70(5):960-5. PubMed ID: 7524606
[TBL] [Abstract][Full Text] [Related]
19. Primary chemotherapy for stage 2 testis cancer.
Abratt RP; McAdam GL; Pontin AR; Barnes RD; Ball HS
S Afr J Surg; 1997 Nov; 35(4):203-5; discussion 205-6. PubMed ID: 9540399
[TBL] [Abstract][Full Text] [Related]
20. [Metallothionein expression as a marker of therapeutic sensitivity in the early stages of testicular cancer].
Eid H; Institoris E; Bodrogi I; Bak M
Orv Hetil; 1997 Jan; 138(3):135-9. PubMed ID: 9064626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
